A combined treatment with selective androgen and estrogen receptor modulators prevents bone loss in orchiectomized rats

[1] Gagnon C(2008)Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment Clin Interv Aging 3 635-645

[2] Li V(2010)Intravenous zolendronic acid: what are the indications for male osteoporosis? Curr Osteoporos Rep 8 4-9

[3] Ebeling PR(2018)Update on osteoporosis in men Best Pract Res Clin Endocrinol Metab 32 759-772

[4] Maricic M(2008)A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men J Bone Miner Res 23 205-214

[5] Adler RA(2018)EAA clinical guideline on management of bone health in the andrological outpatient clinic Andrology 6 272-285

[6] Riggs BL(2003)Testosterone supplementation therapy for older men: potential benefits and risks J Am Geriatr Soc 51 101-115

[7] Melton LJ(2022)Testosterone supplementation and bone parameters: a systematic review and meta-analysis study J Endocrinol Invest 45 911-926

[8] Robb RA(2002)Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone J Bone Miner Res 17 2080-2086

[9] Camp JJ(2018)Estradiol and age-related bone loss in men Physiol Rev 98 1-1516

[10] Atkinson EJ(2002)Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women J Clin Endocrinol Metab 87 1509-1172

[1] Gagnon C(2008)Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment Clin Interv Aging 3 635-645

[2] Li V(2010)Intravenous zolendronic acid: what are the indications for male osteoporosis? Curr Osteoporos Rep 8 4-9

[3] Ebeling PR(2018)Update on osteoporosis in men Best Pract Res Clin Endocrinol Metab 32 759-772

[4] Maricic M(2008)A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men J Bone Miner Res 23 205-214

[5] Adler RA(2018)EAA clinical guideline on management of bone health in the andrological outpatient clinic Andrology 6 272-285

[6] Riggs BL(2003)Testosterone supplementation therapy for older men: potential benefits and risks J Am Geriatr Soc 51 101-115

[7] Melton LJ(2022)Testosterone supplementation and bone parameters: a systematic review and meta-analysis study J Endocrinol Invest 45 911-926

[8] Robb RA(2002)Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone J Bone Miner Res 17 2080-2086

[9] Camp JJ(2018)Estradiol and age-related bone loss in men Physiol Rev 98 1-1516

[10] Atkinson EJ(2002)Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women J Clin Endocrinol Metab 87 1509-1172